Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Park Ridge › NPI 1649928136
Lab

Medlab Technologies LLC

Medlab Technologies LLC was paid $87K by Medicaid between Jul 2022 and May 2023, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 57% of everything it billed.

33Billing provider infoMEDLAB TECHNOLOGIES LLC
PARK RIDGE, IL 60068
33aNPI1649928136assigned 03/14/2022
28Total paid$87K
24GClaims2,785
24DCodes billed5
24AFirst – last monthJul 2022 – May 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#126 of 235
Median peer was paid$123K
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official AHMED, MOHAMMED controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20221,759$72K
20231,026$15K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 57% 663 295 $49K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 18% 644 295 $16K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 18% 663 295 $15K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 6.7% 143 83 $6K
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count <1% 672 661 $432.96

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAHMED, MOHAMMED (PRESIDENT)
Same official

Other billing entities under AHMED, MOHAMMED

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.